Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth

Go back to Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
VERACYTE (NASDAQ: VCYT) Delayed: 58.55 --0 (-0%)
Previous Close $58.55    52 Week High $8.45 
Open $58.55    52 Week Low $4.21 
Day High $58.55    P/E N/A 
Day Low $58.55    EPS $-1.52 
Volume 21